Income Tax Expense (Benefit) of Onconetix, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Onconetix, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
Onconetix, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2024 was $917,997.
Onconetix, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2024 was $1,045,180.
Onconetix, Inc. annual Income Tax Expense (Benefit) for 2024 was $1,045,180, a 8200% decline from 2023.
Onconetix, Inc. annual Income Tax Expense (Benefit) for 2023 was $12,593.
Onconetix, Inc. annual Income Tax Expense (Benefit) for 2022 was $3,158,873,000,000.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Onconetix, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$1,045,180	$917,997	01 Oct 2024	31 Dec 2024	10-K	02 Jun 2025	2024	FY
Q3 2024		$56,384	01 Jul 2024	30 Sep 2024	10-Q	13 Nov 2025	2025	Q3
Q2 2024		$50,768	01 Apr 2024	30 Jun 2024	10-Q	14 Aug 2025	2025	Q2
Q1 2024		$121,567	01 Jan 2024	31 Mar 2024	10-Q	12 Jun 2025	2025	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$1,045,180	-$1,032,587	-8200%	01 Jan 2024	31 Dec 2024	10-K	02 Jun 2025	2024	FY
2023	$12,593	-$3,158,873,012,593		01 Jan 2023	31 Dec 2023	10-K	02 Jun 2025	2024	FY
2022	$3,158,873,000,000^*	+$2,483,143,000,000		01 Jan 2022	31 Dec 2022	10-K	09 Mar 2023	2022	FY
2021	$675,730,000,000^*			01 Jan 2021	31 Dec 2021	10-K	09 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.